Abstract
Hyaluronan (HA) is a core constituent of perineuronal nets (PNNs) that surround subpopulations of neurones. The PNNs control synaptic stabilization in both the developing and adult central nervous system, and disruption of PNNs has shown to reactivate neuroplasticity. We investigated the possibility of memory prolongation by attenuating PNN formation using 4-methylumbelliferone (4-MU), an inhibitor of HA synthesis. Adult C57BL/6 mice were fed with chow containing 5% (w/w) 4-MU for 6 months, at a dose ~6.7 mg/g/day. The oral administration of 4-MU reduced the glycosaminoglycan level in the brain to 72% and the spinal cord to 50% when compared to the controls. Spontaneous object recognition test (SOR) performed at 2, 3, 6 and 7 months showed a significant increase in SOR score in the 6-months treatment group 24 h after object presentation. The effect however did not persist in the washout group (1-month post treatment). Immunohistochemistry confirmed a reduction of PNNs, with shorter and less arborization of aggrecan staining around dendrites in hippocampus after 6 months of 4-MU treatment. Histopathological examination revealed mild atrophy in articular cartilage but it did not affect the motor performance as demonstrated in rotarod test. In conclusion, systemic oral administration of 4-MU for 6 months reduced PNN formation around neurons and enhanced memory retention in mice. However, the memory enhancement was not sustained despite the reduction of PNNs, possibly due to the lack of memory enhancement training during the washout period. Our results suggest that 4-MU treatment might offer a strategy for PNN modulation in memory enhancement.
Highlights
The extracellular matrix (ECM) is a three-dimensional network that provides structural and biochemical support to surrounding cells
Oral doses of 1200 mg/day for 3 months is well tolerated in humans without serious adverse effects and it serves as a dose for exploring new indications [20, 32]
We found that the memory-enhancing effect of 4-MU did not persist 1 month after the end of the 4-MU treatment, and the Spontaneous object recognition test (SOR) score returned to the values as before the treatment
Summary
The extracellular matrix (ECM) is a three-dimensional network that provides structural and biochemical support to surrounding cells. Several proof-of-concept approaches have been developed to e manipulate or remove PNNs to increase the neuroplasticity, memory and CNS repair. These r include enzymatic degradation of ECM molecules [9-11], antibodies blocking PNN inhibitory P action [12], or genetic modifications such as knockout models with gene deletion of various l PNN components [9, 13]. In the CNS, HA is a major component of the loose ECM and PNNs, and has been shown to regulate the differentiation of neural stem cells [14] It forms a backbone of mesh‐like structure which holds the PNNs on neuronal surface and allows for the binding of other important components such as link proteins (haplns), chondroitin sulfate proteoglycans (CSPGs) and tenascin [4, 13, 15]. Prevention of HA biosynthesis might be the effective target for PNN manipulation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.